Table A.1.
Participant baseline characteristics according to the randomization group.
| EX0 (n = 20) | EX500 (n = 20) | EX1000 (n = 20) | |
|---|---|---|---|
| Age, years | 73.3 ± 7.8 | 72 ± 5.1 | 70.3 ± 5.8 |
| Sex, Female | 14 (70) | 13 (65) | 18 (90) |
| Race, White | 14 (70) | 13 (65) | 16 (80) |
| Ethnicity, Hispanic | 1 (5) | 1 (5) | 1 (5) |
| Site, UF | 13 (65) | 14 (70) | 10 (50) |
| Education – professional/graduate degree | 5 (25) | 8 (40) | 10 (50) |
| Height, cm | 163.0 ± 9.5 | 166.1 ± 8.3 | 162.4 ± 6.6 |
| Weight, kg | 83.4 ± 19.8 | 86.1 ± 24.5 | 84.4 ± 19.3 |
| Body Mass Index, kg/m2 | 31.1 ± 5.5 | 31.3 ± 7.6 | 32 ± 6.9 |
| Waist Circumference, cm | 98.4 ± 26.1 | 105 ± 20.3 | 103 ± 17.1 |
| Systolic blood pressure, mm Hg | 140 ± 13.7 | 145 ± 15.1 | 133 ± 9.6 |
| Diastolic blood pressure, mm Hg | 79.3 ± 11.8 | 82.4 ± 9.5 | 78.2 ± 8.2 |
| MMSE, points | 28.2 ± 1.4 | 27.4 ± 2 | 28.7 ± 1.5 |
| CHAMPS Questionnaire, physical activity moderate intensity, min | 53.0 ± 51.8 | 36.6 ± 45 | 30.2 ± 43.3 |
| Chronic Pain Scale, score | 1.2 ± 0.8 | 1.2 ± 0.8 | 0.9 ± 0.5 |
| 400 m walk gait speed, m/s | 1.2 ± 0.2 | 1.2 ± 0.1 | 1.2 ± 0.1 |
| Total number of prescription medications, n | 6 ± 3.4 | 5.3 ± 3.3 | 6.1 ± 4.3 |
| Total number of supplements, n | 3 ± 3.3 | 3.9 ± 2.9 | 2.3 ± 2.6 |
| History of hypertension, n | 15 (79) | 12 (60) | 11 (55) |
| History of diabetes, n | 6 (32) | 8 (42) | 3 (15) |
| History of lower-limb osteoarthritis, n | 2 (10) | 3 (15) | 2 (10) |
Notes: Values represent unadjusted participant baseline demographics and characteristics. Missing data have been excluded from all summary statistics and missing data is assumed to be missing at random. Data are presented as mean ± SD, or n (percentage).
Abbreviations: EX0 = exercise + placebo, EX500 = exercise + 500 mg/d resveratrol, EX1000 = exercise + 1,000 mg/d resveratrol, UF = University of Florida, MMSE = Mini-Mental State Examination, CHAMPS = Community Healthy Activities Model Program for Seniors, SPPB = Short Physical Performance Battery.